PL3986561T3 - Pochodne pirydo[2,3-d]pirymidyny jako inhibitory replikacji ludzkiego wirusa niedoboru odporności - Google Patents
Pochodne pirydo[2,3-d]pirymidyny jako inhibitory replikacji ludzkiego wirusa niedoboru odpornościInfo
- Publication number
- PL3986561T3 PL3986561T3 PL20743783.1T PL20743783T PL3986561T3 PL 3986561 T3 PL3986561 T3 PL 3986561T3 PL 20743783 T PL20743783 T PL 20743783T PL 3986561 T3 PL3986561 T3 PL 3986561T3
- Authority
- PL
- Poland
- Prior art keywords
- pyrido
- replication
- inhibitors
- pyrimidine derivatives
- deficiency virus
- Prior art date
Links
- 241000725303 Human immunodeficiency virus Species 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 159000000018 pyrido[2,3-d]pyrimidines Chemical class 0.000 title 1
- 230000010076 replication Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962863406P | 2019-06-19 | 2019-06-19 | |
| PCT/IB2020/055653 WO2020254985A1 (en) | 2019-06-19 | 2020-06-17 | Pyrido[2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3986561T3 true PL3986561T3 (pl) | 2024-06-10 |
Family
ID=71738195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20743783.1T PL3986561T3 (pl) | 2019-06-19 | 2020-06-17 | Pochodne pirydo[2,3-d]pirymidyny jako inhibitory replikacji ludzkiego wirusa niedoboru odporności |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US12129255B2 (pl) |
| EP (1) | EP3986561B1 (pl) |
| JP (1) | JP7628512B2 (pl) |
| CN (2) | CN114245795B (pl) |
| AR (1) | AR119174A1 (pl) |
| AU (1) | AU2020295793B2 (pl) |
| BR (1) | BR112021025655A2 (pl) |
| CA (1) | CA3143136A1 (pl) |
| CL (1) | CL2021003388A1 (pl) |
| CO (1) | CO2021017479A2 (pl) |
| CR (1) | CR20210664A (pl) |
| DK (1) | DK3986561T3 (pl) |
| ES (1) | ES2974541T3 (pl) |
| FI (1) | FI3986561T3 (pl) |
| HR (1) | HRP20240501T1 (pl) |
| HU (1) | HUE065762T2 (pl) |
| IL (1) | IL288750B2 (pl) |
| LT (1) | LT3986561T (pl) |
| MA (1) | MA56526B1 (pl) |
| MD (1) | MD3986561T2 (pl) |
| MX (1) | MX2021016149A (pl) |
| MY (1) | MY206712A (pl) |
| PE (1) | PE20220510A1 (pl) |
| PH (1) | PH12021553180A1 (pl) |
| PL (1) | PL3986561T3 (pl) |
| PT (1) | PT3986561T (pl) |
| RS (1) | RS65304B1 (pl) |
| SI (1) | SI3986561T1 (pl) |
| SM (1) | SMT202400153T1 (pl) |
| TW (1) | TWI850403B (pl) |
| UA (1) | UA128967C2 (pl) |
| UY (1) | UY38755A (pl) |
| WO (1) | WO2020254985A1 (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113195475A (zh) | 2018-10-24 | 2021-07-30 | Viiv保健英国第五有限公司 | 人免疫缺陷病毒复制的抑制剂 |
| PH12021553180A1 (en) | 2019-06-19 | 2022-11-07 | Viiv Healthcare Uk No 5 Ltd | Inhibitors of human immunodeficiency virus replication |
| US12415771B2 (en) | 2019-06-19 | 2025-09-16 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
| AU2020358156B2 (en) * | 2019-10-01 | 2024-06-06 | Janssen Sciences Ireland Unlimited Company | Method for treating HIV with cabotegravir and rilpivirine |
| CN114786648A (zh) * | 2019-12-09 | 2022-07-22 | Viiv保健公司 | 包含卡博特韦的药物组合物 |
| KR20220151655A (ko) * | 2020-03-06 | 2022-11-15 | 비브 헬스케어 유케이 (넘버5) 리미티드 | 인간 면역결핍 바이러스 복제의 억제제 |
| BR112022020933A2 (pt) * | 2020-04-15 | 2022-12-06 | Viiv Healthcare Uk No 5 Ltd | Inibidores de replicação do vírus da imunodeficiência humana |
| MX2024004551A (es) | 2021-10-13 | 2024-06-26 | Viiv Healthcare Uk No 5 Ltd | Inhibidores de la replicacion del virus de inmunodeficiencia humana. |
| WO2024249592A1 (en) | 2023-05-31 | 2024-12-05 | Gilead Sciences, Inc. | Quinazolinyl-indazole derivatives as therapeutic compounds for hiv |
| TW202515516A (zh) | 2023-06-15 | 2025-04-16 | 英商Ｖｉｉｖ醫療保健英國(Ｎｏ 5)有限公司 | 用於製備化合物之方法及中間物 |
| WO2025169059A1 (en) | 2024-02-05 | 2025-08-14 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030207910A1 (en) | 2001-02-02 | 2003-11-06 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| SK287900B6 (sk) | 2001-02-02 | 2012-03-02 | Bristol-Myers Squibb Company | Substituted azaindolexoacetic piperazine derivatives and pharmaceutical composition containing thereof |
| US8318732B2 (en) * | 2008-07-02 | 2012-11-27 | Avexa Limited | Compounds having antiviral properties |
| CN102464654B (zh) | 2010-11-12 | 2016-01-13 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
| ES2553449T3 (es) | 2011-07-06 | 2015-12-09 | Gilead Sciences, Inc. | Compuestos para el tratamiento de VIH |
| CN102863512B (zh) | 2011-07-07 | 2016-04-20 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
| TW201443037A (zh) | 2013-01-09 | 2014-11-16 | Gilead Sciences Inc | 治療用化合物 |
| US9012441B2 (en) | 2013-01-09 | 2015-04-21 | Gilead Sciences, Inc. | Therapeutic compounds |
| JP5941598B2 (ja) | 2013-01-09 | 2016-06-29 | ギリアード サイエンシーズ， インコーポレイテッド | ５員ヘテロアリールおよびそれらの抗ウイルス剤としての使用 |
| TWI706945B (zh) | 2013-03-01 | 2020-10-11 | 美商基利科學股份有限公司 | 供治療反轉錄病毒科病毒感染之治療性化合物 |
| WO2015130966A1 (en) | 2014-02-28 | 2015-09-03 | Gilead Sciences, Inc. | Antiviral agents |
| WO2015130964A1 (en) | 2014-02-28 | 2015-09-03 | Gilead Sciences, Inc. | Therapeutic compounds |
| AU2015308907B2 (en) | 2014-08-29 | 2018-10-18 | Gilead Sciences, Inc. | Antiretroviral agents |
| SI3347352T1 (sl) * | 2016-08-19 | 2019-08-30 | Gilead Sciences, Inc. | Terapevtske spojine uporabne za profilaktično ali terapevtsko zdravljenje okužbe z virusom HIV |
| ES2826748T3 (es) * | 2016-09-02 | 2021-05-19 | Gilead Sciences Inc | Derivados de 4,6-diamino-pirido[3,2-d]pirimidina como moduladores de receptores de tipo Toll |
| UY37710A (es) * | 2017-05-02 | 2018-11-30 | Viiv Healthcare Uk No 5 Ltd | Inhibidores de la replicación del virus de la inmunodeficiencia humana |
| CN113195475A (zh) * | 2018-10-24 | 2021-07-30 | Viiv保健英国第五有限公司 | 人免疫缺陷病毒复制的抑制剂 |
| UY38559A (es) * | 2019-02-01 | 2020-07-31 | Viiv Healthcare Uk No 5 Ltd | Inhibidores de la replicación del virus de la inmunodeficiencia humana |
| PH12021553180A1 (en) | 2019-06-19 | 2022-11-07 | Viiv Healthcare Uk No 5 Ltd | Inhibitors of human immunodeficiency virus replication |
-
2020
- 2020-06-17 PH PH1/2021/553180A patent/PH12021553180A1/en unknown
- 2020-06-17 AR ARP200101700A patent/AR119174A1/es unknown
- 2020-06-17 RS RS20240309A patent/RS65304B1/sr unknown
- 2020-06-17 MY MYPI2021007563A patent/MY206712A/en unknown
- 2020-06-17 CN CN202080052305.0A patent/CN114245795B/zh active Active
- 2020-06-17 SM SM20240153T patent/SMT202400153T1/it unknown
- 2020-06-17 AU AU2020295793A patent/AU2020295793B2/en active Active
- 2020-06-17 LT LTEPPCT/IB2020/055653T patent/LT3986561T/lt unknown
- 2020-06-17 FI FIEP20743783.1T patent/FI3986561T3/fi active
- 2020-06-17 DK DK20743783.1T patent/DK3986561T3/da active
- 2020-06-17 UA UAA202200207A patent/UA128967C2/uk unknown
- 2020-06-17 HR HRP20240501TT patent/HRP20240501T1/hr unknown
- 2020-06-17 CN CN202410979514.XA patent/CN119039288A/zh active Pending
- 2020-06-17 HU HUE20743783A patent/HUE065762T2/hu unknown
- 2020-06-17 US US17/268,107 patent/US12129255B2/en active Active
- 2020-06-17 MX MX2021016149A patent/MX2021016149A/es unknown
- 2020-06-17 CA CA3143136A patent/CA3143136A1/en active Pending
- 2020-06-17 EP EP20743783.1A patent/EP3986561B1/en active Active
- 2020-06-17 UY UY0001038755A patent/UY38755A/es unknown
- 2020-06-17 IL IL288750A patent/IL288750B2/en unknown
- 2020-06-17 SI SI202030385T patent/SI3986561T1/sl unknown
- 2020-06-17 PT PT207437831T patent/PT3986561T/pt unknown
- 2020-06-17 WO PCT/IB2020/055653 patent/WO2020254985A1/en not_active Ceased
- 2020-06-17 CR CR20210664A patent/CR20210664A/es unknown
- 2020-06-17 MD MDE20220479T patent/MD3986561T2/ro unknown
- 2020-06-17 TW TW109120334A patent/TWI850403B/zh active
- 2020-06-17 MA MA56526A patent/MA56526B1/fr unknown
- 2020-06-17 PL PL20743783.1T patent/PL3986561T3/pl unknown
- 2020-06-17 ES ES20743783T patent/ES2974541T3/es active Active
- 2020-06-17 JP JP2021575482A patent/JP7628512B2/ja active Active
- 2020-06-17 PE PE2021002114A patent/PE20220510A1/es unknown
- 2020-06-17 BR BR112021025655A patent/BR112021025655A2/pt unknown
-
2021
- 2021-12-17 CL CL2021003388A patent/CL2021003388A1/es unknown
- 2021-12-20 CO CONC2021/0017479A patent/CO2021017479A2/es unknown
-
2024
- 2024-09-18 US US18/888,497 patent/US20250019383A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3986561T3 (pl) | Pochodne pirydo[2,3-d]pirymidyny jako inhibitory replikacji ludzkiego wirusa niedoboru odporności | |
| IL281924A (en) | New forms of pyrido[1,2-a]pyrimidin-4-one derivatives, its formulation and its process of making | |
| DK3873884T3 (da) | 3-(quinolin-8-yl)-1,4-dihydropyrido[3,4-d]pyrimidin-2,4-dion-derivater som alpha4beta7-integrinhæmmere til behandling af inflammatoriske sygdomme | |
| DK3784664T3 (da) | 2-amino-pyridin- eller 2-amino-pyrimidinderivater som cyclinafhængige kinasehæmmere | |
| EP3873900C0 (en) | IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS INTEGRIN ALPHA4BETA7 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
| LT3558955T (lt) | Benzizotiazolo, izotiazolo[3,4-b]piridazino ir ftalazino, pirido[2,3-d] piridazino ir pirido[2,3-d]pirimidino dariniai, kaip kras g12c inhibitoriai, skirti plaučių, kasos arba storosios žarnos vėžio gydymui | |
| PL3870574T3 (pl) | Pochodne aminopirymidyny/pirazyny jako inhibitory CTPS1 | |
| HUE057549T2 (hu) | Imidazo[1,2-a]pirimidinszármazékok, eljárás elõállításukra és alkalmazásaik | |
| DK3419978T3 (da) | Pyrazolo[1,5-A]pyrazin-4-yl-derivater som JAK-hæmmere | |
| EA201591255A1 (ru) | ПРОИЗВОДНЫЕ ПИРРОЛО[2,3-d]ПИРИМИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-РОДСТВЕННЫХ КИНАЗ (JAK) | |
| SG11201907095UA (en) | DERIVATIVES OF N-CYCLOALKYL/HETEROCYCLOALKYL-4-(IMIDAZO [1,2-a]PYRIDINE)PYRIMIDIN-2-AMINE AS THERAPEUTIC AGENTS | |
| WO2016142855A3 (en) | Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors | |
| EA201791692A1 (ru) | 4H-ПИРРОЛО[3,2-c]ПИРИДИН-4-ОНОВЫЕ ПРОИЗВОДНЫЕ | |
| MX2017007429A (es) | Derivados de pirazolo[1,5-a]pirimidina sustituida con piperidina con actividad inhibidora sobre la replicacion del virus sincicial respiratorio (vsr). | |
| EP3305785A4 (en) | PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | |
| WO2015120237A3 (en) | 4'-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza rna replication | |
| IL289456A (en) | Eif4e-inhibiting 4-oxo-3,4-dihydropyrido[3,4-d]pyrimidine compounds | |
| ZA201701214B (en) | Imidazo[1,2-a]pyridine derivatives for use as inhibitors of human immunodeficiency virus replication | |
| TWI799399B (zh) | 吡啶并〔３，４－ｄ〕嘧啶衍生物及其藥學上所容許之鹽 | |
| PL4010330T3 (pl) | Pochodne chinoliny jako inhibitory kinazy białkowej | |
| CL2017001543A1 (es) | Formulaciones farmacéuticas de inhibidores de la cinasa relacionada con tropomiosina (trk) | |
| PL3737684T3 (pl) | Pochodne 2,4,6,7-tetrahydropirazolo[4,3-d]pirymidyn-5-onu i związki pokrewne jako modulatory receptorów c5a do leczenia zapalenia naczyń i chorób zapalnych | |
| DK3679042T3 (da) | Imidazo[1,5-A]pyrazin-derivater som PI3Kdelta-inhibitorer | |
| EA201791743A1 (ru) | Производные имидазо[2,1-в]тиазола и 5,6-дигидроимидазо[2,1-в]тиазола, применяемые в качестве s100-ингибиторов | |
| DK3823972T3 (da) | Imidazo[1,2-b]pyridazinderivater som trk-inhibitorer |